Previous studies have implicated a possible role for AR in breast cancers [12–14], and AR is found to be predominantly expressed in in-situ, invasive and metastatic breast cancers (~90% of primary tumors and 75% of metastases) [15–18]; however, the precise molecular mechanism(s) for AR's contribution to breast cancer is largely unknown. This evidence concerns the gene AR and breast carcinoma.